Medicines Position Statements – NEL

NEL

Branded generics

LPP and London Diabetes Network joint statement: Access to continuous glucose monitors for adults living with type 2 diabetes in London

IQoro® position statement for hiatus hernia and reflux, stroke-related dysphagia and other indications (NEL)_02.2024

Position statement on generic and brand prescribing (NEL)

Preferred DOAC prescribing position statement (NEL)_11.25

Initiation of statins for primary prevention of cardiovascular disease in patients with Liver disease

Items which should not be routinely prescribed in primary care in North East London

Bath and Shower Preparations PIL

Dosulepin PIL

Doxazosin PIL

Herbal Treatments PIL

Immediate Release Fentanyl PIL

Lidocaine Plasters PIL

Liothyronine PIL

Needles PIL

Omega-3 Fatty Acid Compounds PIL

Oxycodone and Naloxone Combination Products PIL

Rubefacients PIL

Trimipramine PIL

This website is for healthcare professions only.

It is not for public use.

Feedback
Feedback
How would you rate your experience?
Do you have any additional comment?
Next
Enter your email if you'd like us to contact you regarding with your feedback.
Back
Submit
Thank you for submitting your feedback!